Paclitaxel-releasing balloon catheter - Blue Medical

Drug Profile

Paclitaxel-releasing balloon catheter - Blue Medical

Alternative Names: Protege DEB Catheter; Protege DEB NC; Protege non compliant DEB Catheter; Protégé; Protégé NC

Latest Information Update: 12 Nov 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Blue Medical
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery disease

Most Recent Events

  • 30 May 2013 Biomarkers information updated
  • 30 Oct 2012 Registered for Coronary artery disease (non-compliant paclitaxel-eluting balloon incorporating Force® catheter) in European Union (Intracoronary)
  • 20 Mar 2012 Launched for Coronary artery disease in European Union (Intracoronary) - first global launch
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top